Abstract
Neurological infections are an important part of neuroimmunology. The concepts and issues dealt with in the previous chapters have covered neurological inflammatory diseases that are considered “autoimmune” primarily because no pathogen has yet been identified. These diseases also have relevance to neurological inflammatory diseases in which pathogens have been identified. The nervous system has only a limited repertoire with respect to inflammation. Processes such as microglial proliferation, loss of blood–brain barrier function, immune cell infiltration into the CNS, have already been discussed and function similarly in neurological infections as they do in autoimmune diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Pachner AR. Lyme disease. Trends Neurosci. 1989;12(5):177–81.
Scheld WM, Whitley RJ, Marra CM, editors. Infections of the central nervous system. 3rd ed. Philadelphia: Lippincott-Williams; 2004.
Roos KL, editor. Principles of neurologic infectious diseases. New York: McGraw-Hill; 2005.
Pachner AR, Dail D, Bai Y, et al. Genotype determines phenotype in experimental Lyme borreliosis. Ann Neurol. 2004;56(3):361–70.
Pachner AR, Basta J, Delaney E, Hulinska D. Localization of Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy. Am J Trop Med Hyg. 1995;52(2):128–33.
Kaiser R. Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins. J Neurol. 1995;242(5):319–25.
Clark JR, Carlson RD, Sasaki CT, Pachner AR, Steere AC. Facial paralysis in Lyme disease. Laryngoscope. 1985;95(11):1341–5.
Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985;35(1):47–53.
Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain. 1992;115(Pt 2):399–423.
Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med. 1983;99(6):767–72.
Ljostad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690–5.
van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354(1):44–53.
Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS. 2007;21(16):2119–29.
Be NA, Kim KS, Bishai WR, Jain SK. Pathogenesis of central nervous system tuberculosis. Curr Mol Med. 2009;9(2):94–9.
Anderson NE, Willoughby EW. Chronic meningitis without predisposing illness – a review of 83 cases. Q J Med. 1987;63(240):283–95.
Savarin C, Bergmann CC. Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr Opin Pharmacol. 2008;8(4):472–9.
Pessach I, Walter J, Notarangelo LD. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr Res. 2009;65(5 Pt 2):3R–12.
Skoldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2(8405):707–11.
Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314(3):144–9.
Singer EJ, Valdes-Sueiras M, Commins D, Levine A. Neurologic presentations of AIDS. Neurol Clin. 2010;28(1):253–75.
Robertson KR, Su Z, Margolis DM, et al. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010;74(16):1260–6.
Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(4):251–61.
Tan K, Roda R, Ostrow L, McArthur J, Nath A. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology. 2009;72(17):1458–64.
Gyure KA. West Nile Virus Infections. J Neuropathol Exp Neurol. 2009;68(10):1053–60.
Lipton HL. Human Vilyuisk encephalitis. Rev Med Virol. 2008;18(5):347–52.
Bleharski JR, Li H, Meinken C, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science. 2003;301(5639):1527–30.
Steiner I, Kennedy PG, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 2007;6(11):1015–28.
Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med. 2010;362(5):402–15.
Cohen BA. Neurologic manifestations of toxoplasmosis in AIDS. Semin Neurol. 1999;19(2):201–11.
Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9(4):425–37.
Marra CM. Update on neurosyphilis. Curr Infect Dis Rep. 2009;11(2):127–34.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Pachner, A.R. (2012). A Introduction to Neurological Infections: Neuro-infectious Disease as Part of Neuroimmunology. In: A Primer of Neuroimmunological Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-2188-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2188-7_12
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-2187-0
Online ISBN: 978-1-4614-2188-7
eBook Packages: MedicineMedicine (R0)